Cargando…

The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer

Macroautophagy/autophagy is a cellular process to recycle damaged cellular components, and its modulation can be exploited for disease treatments. A key autophagy player is the ubiquitin-like protein MAP1LC3B/LC3B. Mutations and changes in MAP1LC3B expression occur in cancer samples. However, the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fas, Burcu Aykac, Maiani, Emiliano, Sora, Valentina, Kumar, Mukesh, Mashkoor, Maliha, Lambrughi, Matteo, Tiberti, Matteo, Papaleo, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525936/
https://www.ncbi.nlm.nih.gov/pubmed/33302793
http://dx.doi.org/10.1080/15548627.2020.1847443
_version_ 1784585781676867584
author Fas, Burcu Aykac
Maiani, Emiliano
Sora, Valentina
Kumar, Mukesh
Mashkoor, Maliha
Lambrughi, Matteo
Tiberti, Matteo
Papaleo, Elena
author_facet Fas, Burcu Aykac
Maiani, Emiliano
Sora, Valentina
Kumar, Mukesh
Mashkoor, Maliha
Lambrughi, Matteo
Tiberti, Matteo
Papaleo, Elena
author_sort Fas, Burcu Aykac
collection PubMed
description Macroautophagy/autophagy is a cellular process to recycle damaged cellular components, and its modulation can be exploited for disease treatments. A key autophagy player is the ubiquitin-like protein MAP1LC3B/LC3B. Mutations and changes in MAP1LC3B expression occur in cancer samples. However, the investigation of the effects of these mutations on MAP1LC3B protein structure is still missing. Despite many LC3B structures that have been solved, a comprehensive study, including dynamics, has not yet been undertaken. To address this knowledge gap, we assessed nine physical models for biomolecular simulations for their capabilities to describe the structural ensemble of MAP1LC3B. With the resulting MAP1LC3B structural ensembles, we characterized the impact of 26 missense mutations from pan-cancer studies with different approaches, and we experimentally validated our prediction for six variants using cellular assays. Our findings shed light on damaging or neutral mutations in MAP1LC3B, providing an atlas of its modifications in cancer. In particular, P32Q mutation was found detrimental for protein stability with a propensity to aggregation. In a broader context, our framework can be applied to assess the pathogenicity of protein mutations or to prioritize variants for experimental studies, allowing to comprehensively account for different aspects that mutational events alter in terms of protein structure and function. Abbreviations: ATG: autophagy-related; Cα: alpha carbon; CG: coarse-grained; CHARMM: Chemistry at Harvard macromolecular mechanics; CONAN: contact analysis; FUNDC1: FUN14 domain containing 1; FYCO1: FYVE and coiled-coil domain containing 1; GABARAP: GABA type A receptor-associated protein; GROMACS: Groningen machine for chemical simulations; HP: hydrophobic pocket; LIR: LC3 interacting region; MAP1LC3B/LC3B microtubule associated protein 1 light chain 3 B; MD: molecular dynamics; OPTN: optineurin; OSF: open software foundation; PE: phosphatidylethanolamine, PLEKHM1: pleckstrin homology domain-containing family M 1; PSN: protein structure network; PTM: post-translational modification; SA: structural alphabet; SLiM: short linear motif; SQSTM1/p62: sequestosome 1; WT: wild-type.
format Online
Article
Text
id pubmed-8525936
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-85259362021-10-20 The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer Fas, Burcu Aykac Maiani, Emiliano Sora, Valentina Kumar, Mukesh Mashkoor, Maliha Lambrughi, Matteo Tiberti, Matteo Papaleo, Elena Autophagy Research Paper Macroautophagy/autophagy is a cellular process to recycle damaged cellular components, and its modulation can be exploited for disease treatments. A key autophagy player is the ubiquitin-like protein MAP1LC3B/LC3B. Mutations and changes in MAP1LC3B expression occur in cancer samples. However, the investigation of the effects of these mutations on MAP1LC3B protein structure is still missing. Despite many LC3B structures that have been solved, a comprehensive study, including dynamics, has not yet been undertaken. To address this knowledge gap, we assessed nine physical models for biomolecular simulations for their capabilities to describe the structural ensemble of MAP1LC3B. With the resulting MAP1LC3B structural ensembles, we characterized the impact of 26 missense mutations from pan-cancer studies with different approaches, and we experimentally validated our prediction for six variants using cellular assays. Our findings shed light on damaging or neutral mutations in MAP1LC3B, providing an atlas of its modifications in cancer. In particular, P32Q mutation was found detrimental for protein stability with a propensity to aggregation. In a broader context, our framework can be applied to assess the pathogenicity of protein mutations or to prioritize variants for experimental studies, allowing to comprehensively account for different aspects that mutational events alter in terms of protein structure and function. Abbreviations: ATG: autophagy-related; Cα: alpha carbon; CG: coarse-grained; CHARMM: Chemistry at Harvard macromolecular mechanics; CONAN: contact analysis; FUNDC1: FUN14 domain containing 1; FYCO1: FYVE and coiled-coil domain containing 1; GABARAP: GABA type A receptor-associated protein; GROMACS: Groningen machine for chemical simulations; HP: hydrophobic pocket; LIR: LC3 interacting region; MAP1LC3B/LC3B microtubule associated protein 1 light chain 3 B; MD: molecular dynamics; OPTN: optineurin; OSF: open software foundation; PE: phosphatidylethanolamine, PLEKHM1: pleckstrin homology domain-containing family M 1; PSN: protein structure network; PTM: post-translational modification; SA: structural alphabet; SLiM: short linear motif; SQSTM1/p62: sequestosome 1; WT: wild-type. Taylor & Francis 2020-12-11 /pmc/articles/PMC8525936/ /pubmed/33302793 http://dx.doi.org/10.1080/15548627.2020.1847443 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Research Paper
Fas, Burcu Aykac
Maiani, Emiliano
Sora, Valentina
Kumar, Mukesh
Mashkoor, Maliha
Lambrughi, Matteo
Tiberti, Matteo
Papaleo, Elena
The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer
title The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer
title_full The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer
title_fullStr The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer
title_full_unstemmed The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer
title_short The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer
title_sort conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525936/
https://www.ncbi.nlm.nih.gov/pubmed/33302793
http://dx.doi.org/10.1080/15548627.2020.1847443
work_keys_str_mv AT fasburcuaykac theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT maianiemiliano theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT soravalentina theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT kumarmukesh theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT mashkoormaliha theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT lambrughimatteo theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT tibertimatteo theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT papaleoelena theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT fasburcuaykac conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT maianiemiliano conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT soravalentina conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT kumarmukesh conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT mashkoormaliha conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT lambrughimatteo conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT tibertimatteo conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer
AT papaleoelena conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer